Reduced albumin levels and utilization of arteriovenous access in pediatric patients with systemic lupus erythematosus (SLE)

作者: Sangeeta D. Sule , Jeffrey J. Fadrowski , Barbara A. Fivush , Gregory Gorman , Susan L. Furth

DOI: 10.1007/S00467-007-0591-2

关键词: NephrologyMedicineKidneyInternal medicineIntensive care medicineAutoimmune diseaseKidney diseaseDialysisDiseaseHemodialysisEnd stage renal disease

摘要: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects between five and ten thousand children in the USA. Kidney may progress to end-stage renal (ESRD) subsequent need for dialysis therapy a significant number of with SLE. We performed cross-sectional analysis comparing achievement National Foundation/Kidney Disease Outcomes Quality Initiative clinical targets pediatric patients SLE maintained on hemodialysis (HD) other causes ESRD. Ninety-seven unique two control groups—1,823 ESRD 694 glomerulonephritis—were identified End Stage Renal Clinical Performance Measures 2000–2004 Project Years. were older, female black race predominance compared both groups. Pediatric HD secondary less likely meet albumin more have vascular catheters than causes. These findings be associated increased morbidity mortality deserve further study.

参考文章(32)
D. P. M. Symmons, J. Osborne, J. Sills, T. R. Southwood, P. Woo, M. Jones, Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register The Journal of Rheumatology. ,vol. 23, pp. 1975- 1980 ,(1996)
Paul E. Barre, John D. Harnett, Gloria M. Kent, David C. Murray, Robert N. Foley, Patrick S. Parfrey, HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL DISEASE Journal of The American Society of Nephrology. ,vol. 7, pp. 728- 736 ,(1996) , 10.1681/ASN.V75728
Paolo Altieri, Giovanna Sau, Riccardo Cao, Antonio Barracca, Amalia Menneas, Benigna Micchittu, Gianfranca Cabiddu, Paola Esposito, Antonello Pani, Immunosuppressive treatment in dialysis patients Nephrology Dialysis Transplantation. ,vol. 17, pp. 2- 9 ,(2002) , 10.1093/NDT/17.SUPPL_8.2
Helen Lee, Braden Manns, Ken Taub, William A. Ghali, Stafford Dean, David Johnson, Cam Donaldson, Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. American Journal of Kidney Diseases. ,vol. 40, pp. 611- 622 ,(2002) , 10.1053/AJKD.2002.34924
M.M. Avram, Neal Mittman, Luigi Bonomini, Jyoti Chattopadhyay, Paul Fein, Markers for survival in dialysis : a seven-year prospective study American Journal of Kidney Diseases. ,vol. 26, pp. 209- 219 ,(1995) , 10.1016/0272-6386(95)90176-0
Jeffrey J. Fadrowski, Wenke Hwang, Diane L. Frankenfield, Barbara A. Fivush, Alicia M. Neu, Susan L. Furth, Clinical Course Associated with Vascular Access Type in a National Cohort of Adolescents Who Receive Hemodialysis: Findings from the Clinical Performance Measures and US Renal Data System Projects Clinical Journal of the American Society of Nephrology. ,vol. 1, pp. 987- 992 ,(2006) , 10.2215/CJN.00530206
Claudio Ronco, Rinaldo Bellomo, New CRRT systems: Impact on dose delivery American Journal of Kidney Diseases. ,vol. 30, ,(1997) , 10.1016/S0272-6386(97)90537-0
Dorothee Stichweh, Edsel Arce, Virginia Pascual, Update on pediatric systemic lupus erythematosus. Current Opinion in Rheumatology. ,vol. 16, pp. 577- 587 ,(2004) , 10.1097/01.BOR.0000137852.42270.0F